• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bioavailability and reversible metabolism of prednisone and prednisolone in man.

作者信息

Garg V, Jusko W J

机构信息

Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo 14260.

出版信息

Biopharm Drug Dispos. 1994 Mar;15(2):163-72. doi: 10.1002/bdd.2510150208.

DOI:10.1002/bdd.2510150208
PMID:8011967
Abstract

The pharmacokinetics of prednisone and prednisolone was examined in 12 healthy male subjects to assess the bioavailability and the parameters of reversible metabolism between the two steroids. After an oral prednisone dose of 0.8 mg kg-1 and an intravenous prednisolone dose of 0.66 mg kg-1, the bioavailability was found to be about 62%. The fraction of the dose recovered in the urine as the hydroxylated metabolites of prednisone and prednisolone was lower after the oral prednisone dose, suggesting that poor absorption of prednisone was the main cause of the low bioavailability. There was a high degree of interconversion between prednisone and prednisolone with 76% of the dose being recycled. The formation clearance of prednisolone from prednisone is much greater than the formation clearance of prednisone from prednisolone or the irreversible elimination clearances of the two steroids. The possible dose dependences of bioavailability and interconversion may be important factors in prednisolone therapy.

摘要

相似文献

1
Bioavailability and reversible metabolism of prednisone and prednisolone in man.
Biopharm Drug Dispos. 1994 Mar;15(2):163-72. doi: 10.1002/bdd.2510150208.
2
Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.
J Pharmacokinet Biopharm. 1990 Oct;18(5):401-21. doi: 10.1007/BF01061702.
3
Effects of thyroid dysfunction on prednisolone and prednisone interconversion and disposition in the rat.
Drug Metab Dispos. 1990 Jul-Aug;18(4):403-8.
4
[Pharmacokinetic parameters of prednisone and prednisolone in healthy volunteers].[健康志愿者中泼尼松和泼尼松龙的药代动力学参数]
Ann Med Interne (Paris). 1990;141(6):507-11.
5
Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses.
J Clin Pharmacol. 1988 Jan;28(1):81-7. doi: 10.1002/j.1552-4604.1988.tb03105.x.
6
A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.两种口服液体糖皮质激素制剂的药代动力学比较。
Pharmacotherapy. 1997 Mar-Apr;17(2):353-6.
7
Dose dependent pharmacokinetics of prednisone and prednisolone in man.泼尼松和泼尼松龙在人体中的剂量依赖性药代动力学。
J Pharmacokinet Biopharm. 1981 Aug;9(4):389-417. doi: 10.1007/BF01060885.
8
Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.吸烟对泼尼松、泼尼松龙和地塞米松药代动力学的影响。
J Pharmacokinet Biopharm. 1981 Feb;9(1):1-14. doi: 10.1007/BF01059339.
9
Prednisone and prednisolone bioavailability in renal transplant patients.泼尼松和泼尼松龙在肾移植患者中的生物利用度。
Kidney Int. 1982 Apr;21(4):621-6. doi: 10.1038/ki.1982.69.
10
Clinical pharmacokinetics of prednisone and prednisolone.
Clin Pharmacokinet. 1979 Mar-Apr;4(2):111-28. doi: 10.2165/00003088-197904020-00004.

引用本文的文献

1
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity.系统性红斑狼疮患者中泼尼松龙的群体药代动力学建模:暴露与疾病活动分析。
Br J Clin Pharmacol. 2025 Oct;91(10):2854-2864. doi: 10.1002/bcp.70103. Epub 2025 May 23.
2
Biotransformation of Δ-Progesterone Using Selected Entomopathogenic Filamentous Fungi and Prediction of Its Products' Bioactivity.Δ-孕烯醇酮的生物转化利用选择的昆虫病原丝状真菌及其产物生物活性的预测。
Int J Mol Sci. 2023 Dec 29;25(1):508. doi: 10.3390/ijms25010508.
3
Urinary Free Cortisol Determination and Interferences Studies Using Liquid Chromatography Coupled to Tandem Mass Spectrometry after On-Line Solid Phase Extraction Based on Turboflow Chromatography.
基于TurboFlow色谱在线固相萃取后,使用液相色谱-串联质谱法测定尿游离皮质醇及干扰研究
Metabolites. 2023 Oct 9;13(10):1063. doi: 10.3390/metabo13101063.
4
The Physiological and Pharmacological Significance of the Circadian Timing of the HPA Axis: A Mathematical Modeling Approach.HPA 轴昼夜节律时间的生理和药理学意义:一种数学建模方法。
J Pharm Sci. 2024 Jan;113(1):33-46. doi: 10.1016/j.xphs.2023.08.005. Epub 2023 Aug 18.
5
Interventions for bullous pemphigoid.大疱性类天疱疮的治疗。
Cochrane Database Syst Rev. 2023 Aug 11;8(8):CD002292. doi: 10.1002/14651858.CD002292.pub4.
6
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.从基础到系统药效动力学模型的转变:皮质类固醇的经验教训。
Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101.
7
How can we minimise the use of regular oral corticosteroids in asthma?我们如何才能最大限度地减少哮喘患者常规口服皮质类固醇的使用?
Eur Respir Rev. 2020 Feb 5;29(155). doi: 10.1183/16000617.0085-2019. Print 2020 Mar 31.
8
Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy.健康男性和男孩中沃莫罗龙(VBP15)的群体药代动力学研究。
J Clin Pharmacol. 2019 Jul;59(7):979-988. doi: 10.1002/jcph.1388. Epub 2019 Feb 11.
9
The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate.经 PEG 化脂质体磷酸泼尼松龙给药后小鼠体内药物包封和释放的个体药代动力学和组织分布:药物通过脂质体药物传递的可用性。
Invest New Drugs. 2019 Oct;37(5):890-901. doi: 10.1007/s10637-018-0708-4. Epub 2018 Dec 13.
10
Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.糖尿病稳定期肾移植受者中总泼尼松和泼尼松龙以及游离泼尼松和泼尼松龙的药代动力学
Ther Drug Monit. 2014 Aug;36(4):448-55. doi: 10.1097/FTD.0000000000000045.